418.85
+35.40
+(9.23%)
At close: 3:30:02 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
18,062,570
17,686,570
20,047,050
19,260,300
17,070,520
Cost of Revenue
8,787,330
8,640,330
11,422,690
10,332,520
9,366,400
Gross Profit
9,275,240
9,046,240
8,624,360
8,927,780
7,704,120
Operating Expense
7,568,560
7,549,560
7,135,110
6,478,900
5,317,980
Operating Income
1,706,680
1,496,680
1,489,250
2,448,880
2,386,140
Net Non Operating Interest Income Expense
-706,120
-544,120
-435,920
-278,260
-335,310
Pretax Income
1,028,050
955,050
1,053,650
2,185,590
2,064,250
Tax Provision
282,030
259,030
269,830
580,600
732,850
Net Income Common Stockholders
746,020
696,020
783,820
1,604,990
1,331,400
Diluted NI Available to Com Stockholders
746,020
696,020
783,820
1,604,990
1,331,400
Basic EPS
6.04
5.64
6.36
13.02
10.80
Diluted EPS
6.04
5.64
6.36
13.02
10.80
Basic Average Shares
123,466.40
123,300.75
123,300.75
123,300.75
123,300.75
Diluted Average Shares
123,466.40
123,300.75
123,300.75
123,300.75
123,300.75
Rent Expense Supplemental
--
20,250
25,270
40,680
35,080
Total Expenses
16,355,890
16,189,890
18,557,800
16,811,420
14,684,380
Net Income from Continuing & Discontinued Operation
746,020
696,020
783,820
1,604,990
1,331,400
Normalized Income
742,159.46
692,142.78
780,442.65
1,603,579.95
1,337,598.26
Interest Income
--
16,950
19,560
17,560
26,670
Interest Expense
693,540
531,540
409,330
261,920
319,450
Net Interest Income
-706,120
-544,120
-435,920
-278,260
-335,310
EBIT
1,721,590
1,486,590
1,462,980
2,447,510
2,383,700
EBITDA
3,011,700
2,662,700
2,553,110
3,404,200
3,236,150
Reconciled Cost of Revenue
8,787,330
8,640,330
11,422,690
10,332,520
9,366,400
Reconciled Depreciation
1,290,110
1,176,110
1,090,130
956,690
852,450
Net Income from Continuing Operation Net Minority Interest
746,020
696,020
783,820
1,604,990
1,331,400
Total Unusual Items Excluding Goodwill
5,320
5,320
4,540
1,920
-9,610
Total Unusual Items
5,320
5,320
4,540
1,920
-9,610
Normalized EBITDA
3,006,380
2,657,380
2,548,570
3,402,280
3,245,760
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,459.46
1,442.78
1,162.65
509.95
-3,411.74
3/31/2021 - 7/1/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FDC.NS FDC Limited
421.50
+3.61%
IOLCP.NS IOL Chemicals and Pharmaceuticals Limited
61.65
+3.88%
GLENMARK.NS Glenmark Pharmaceuticals Limited
1,378.10
+0.13%
PPLPHARMA.NS Piramal Pharma Limited
219.83
+5.50%
LAURUSLABS.NS Laurus Labs Limited
605.85
+7.37%
SPARC.NS Sun Pharma Advanced Research Company Limited
145.48
+1.29%
WINDLAS.NS Windlas Biotech Limited
967.05
+8.38%
AARTIPHARM.NS Aarti Pharmalabs Limited
679.40
+8.81%
RPGLIFE.NS RPG Life Sciences Limited
2,063.95
+4.80%
BLISSGVS.NS Bliss GVS Pharma Limited
119.02
+2.24%